脑膜炎疫苗市场按类型、品牌、血清型、销售管道和地区划分

预计 2025 年全球脑膜炎疫苗市场规模为 39.7 亿美元，到 2032 年将达到 63 亿美元，2025 年至 2032 年的复合年增长率为 6.8%。

数字。 2025年脑膜炎疫苗市场占有率（按地区）

脑膜炎是覆盖大脑和脊髓的保护膜（即脑膜）的一种潜在致命的发炎。脑膜炎可由多种病原体引起，包括细菌、病毒、寄生虫和真菌。脑膜炎最常见的原因是病毒和细菌感染。如果没有及时使用适当的抗生素治疗，由脑膜炎奈瑟菌、肺炎链球菌和 B 型流感嗜血桿菌引起的细菌感染会迅速变得严重，甚至致命。虽然及时使用抗生素治疗可以治癒大多数细菌性脑膜炎病例，但 10-15％ 的病例仍会导致长期残疾，如听力丧失、神经发育迟缓、癫痫和截肢。建议接种疫苗，以预防脑膜炎奈瑟菌引起的侵袭性脑膜炎双球菌疾病。脑膜炎球菌结合疫苗已被开发出来，可以提供直接保护和群体免疫，有效地限制疾病在社区内的传播。

市场动态

全球脑膜炎疫苗市场的成长主要受到侵袭性脑膜炎双球菌病菌感染负担的增加以及世界各地大规模疫苗接种计划的实施的推动。例如，根据世界卫生组织2021年发布的资料，脑膜炎每年导致约25万至50万例病例和3万多例死亡，是公共卫生优先事项。预计在预测期内，引起疫情爆发的常见致病血清群的流行病学演变、各国监管机构的常规疫苗接种建议以及联合疫苗的可用性将为市场提供强劲的成长机会。然而，製造和开发新疫苗的高成本、疫情期间疫苗缺货以及中低收入国家缺乏认知等因素可能会阻碍市场发展。涵盖新兴血清型的可负担多效价疫苗的开发以及开发中国家免疫计划的扩大为参与者进入和进一步扩大市场提供了有利可图的机会。

本研究的主要特点

本报告对全球脑膜炎疫苗市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

全球脑膜炎疫苗市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数列出的。

从本报告中获得的见解将使负责人和企业经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球脑膜炎疫苗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 流行病学

4. 脑膜炎疫苗市场（按类型），2020-2032 年（十亿美元）

• 二价
• 四价
• 其他的

5. 脑膜炎疫苗市场（按品牌划分），2020-2032 年（十亿美元）

• 门夸德菲
• 门贝奥
• 托尔门巴
• 贝克塞洛
• 其他的

6. 脑膜炎疫苗市场，依年龄族群，2020-2032 年（十亿美元）

• 婴儿
• 成人

7. 脑膜炎疫苗市场，依血清型，2020-2032 年（十亿美元）

• A血清群
• B血清群
• C血清群
• 血清型W-135
• 其他的

8. 脑膜炎疫苗市场，依销售管道，2020-2032 年（十亿美元）

• 私人的
• 公共

9. 脑膜炎疫苗市场（按地区划分），2020-2032 年（十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• Pfizer Inc.
• Sanofi
• GSK plc.
• Serum Institute of India Ltd.
• Merck & co., Inc.
• Walvax Biotechnology Co., Ltd.
• Icepta Pharmaceuticals Ltd.
• Hualan Biological Engineering Inc.

第 11 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Meningitis Vaccines Market is estimated to be valued at USD 3.97 Bn in 2025 and is expected to reach USD 6.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Figure. Meningitis Vaccines Market Share (%), By Region 2025

Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000-500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study

This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

• Type Insights
  • Bivalent
  • Quadrivalent
  • Others
• Brand Insights
  • MenQuadfi
  • Menveo
  • Trumenba
  • Bexsero
  • Others
• Age Group Insights
  • Infants
  • Adults
• Serotype Insights
  • Serotype A
  • Serotype B
  • Serotype C
  • Serotype W-135
  • Others
• Sales Channel Insights
  • Private
  • Public
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Pfizer Inc.
  • Sanofi
  • GSK plc.
  • Serum Institute of India Ltd.
  • Merck & co., Inc.
  • Walvax Biotechnology Co., Ltd.
  • Icepta Pharmaceuticals Ltd.
  • Hualan Biological Engineering Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Meningitis Vaccines Market, By Type
  • Meningitis Vaccines Market, By Brand
  • Meningitis Vaccines Market, By Age Group
  • Meningitis Vaccines Market, By Serotype
  • Meningitis Vaccines Market, By Sales Channel
  • Meningitis Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology

4. Meningitis Vaccines Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Quadrivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Meningitis Vaccines Market, By Brand, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• MenQuadfi
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Menveo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Trumenba
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bexsero
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Meningitis Vaccines Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Meningitis Vaccines Market, By Serotype, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Serotype A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype B
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype C
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype W-135
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Meningitis Vaccines Market, By Sales Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Private
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Public
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Meningitis Vaccines Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country/Region, 2020 - 2032, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GSK plc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Serum Institute of India Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Walvax Biotechnology Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Icepta Pharmaceuticals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hualan Biological Engineering Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us